Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.09 AUD
Change Today 0.00 / 0.00%
Volume 16.3K
As of 10:45 PM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

avita medical ltd (AVH) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/16/14 - A$0.12
52 Week Low
04/7/15 - A$0.06
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AVITA MEDICAL LTD (AVH)

Related News

No related news articles were found.

avita medical ltd (AVH) Related Businessweek News

No Related Businessweek News Found

avita medical ltd (AVH) Details

Avita Medical Limited, a medical device company, develops and distributes regenerative medicine and respiratory products in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. The company develops and distributes tissue-engineered products for the treatment of wounds and other skin defects. Its lead product is ReCell, an autologous cell harvesting, processing, and delivery technology that enable surgeons and clinicians to treat skin defects using the patient's own cells in a regenerative process for use in various wound, plastic, reconstructive, burn, and cosmetic procedures. The company also manufactures and sells a range of spacers, including Funhaler incentive asthma spacer for the paediatric market; and Breath-A-Tech spacer for the adolescent and adult markets. Avita Medical Limited is headquartered in Royston, the United Kingdom.

21 Employees
Last Reported Date: 09/26/14

avita medical ltd (AVH) Top Compensated Officers

Chief Financial Officer and Chief Operating O...
Total Annual Compensation: A$328.9K
Vice President of Research & Technology
Total Annual Compensation: A$235.0K
Company Secretary
Total Annual Compensation: A$36.0K
General Manager of Asia Pacific
Total Annual Compensation: A$184.9K
Vice President of Operations and Quality
Total Annual Compensation: A$153.4K
Compensation as of Fiscal Year 2014.

avita medical ltd (AVH) Key Developments

Avita Medical Limited Reports Sales Results for the Fourth Quarter Ended June 30, 2015

Avita Medical Limited reported sales results for the fourth quarter ended June 30, 2015. Fourth quarter total sales (for regenerative as well as legacy respiratory products) increased by 25% year-over-year and 51% versus the previous quarter.

Avita Medical Ltd Receives a Ce Mark for a New Recell Device for the Treatment of Burns

Avita Medical Ltd. announced that it has received a CE Mark for a new ReCell device for the treatment of burns. This enhanced ReCell product offers treatment of up to a 1. The CE Marking is a legally-required mark for a product that is intended for sale in the European Market and declares that the product complies with the essential requirements of the relevant European health, safety and environmental protection legislation.

Avita Medical Limited Announces Executive Changes

Avita Medical Ltd. announced the appointment of Mr. Adam Kelliher as Chief Executive Officer. Tim Rooney, who has been serving as Interim Chief Executive Officer, will resume his role as the company's Chief Financial Officer and Chief Operating Officer. Mr. Kelliher is a successful entrepreneur with a strong marketing background and a track record of creating and building life science companies. He previously founded Equateq Limited (2006). He also started Equazen Limited (2000). Equazen was sold to Galencia of Switzerland in December, 2007.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AVH:AU A$0.09 AUD 0.00

AVH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AVH.
View Industry Companies

Industry Analysis


Industry Average

Valuation AVH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 9.6x
Price/Book 11.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 11.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AVITA MEDICAL LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at